SHPH
ShuttleยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SHPH Profile
Shuttle Pharmaceuticals Holdings, Inc.
A biotechnology company with a focus on radiation therapy
401 Professional Drive, Suite 260, Gaithersburg, MD 20879
--
Shuttle Pharmaceuticals Holdings, Inc., was incorporated as a limited liability company in December 2012 and transformed into C Company Shuttle Pharmaceuticals, Inc. (" Shuttle ") in August 2016. In June 2018, Shuttle completed a share exchange with Shuttle Pharma Acquisition Corp., pursuant to which Shuttle Pharmaceuticals, Inc., became a subsidiary of Acquisition Corp., Acquisition Corp.'s name was subsequently changed to Shuttle Pharmaceuticals Holdings, Inc. The company is a clinical-stage pharmaceutical company that uses proprietary technology to develop new therapies aimed at curing cancer. The company's goal is to expand the benefits of cancer treatment through surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the most effective ways to treat cancer. The company is developing a range of products designed to address the limitations of current cancer therapies and expand to new applications of radiotherapy.
